Bewersdorf, J. P., & Zeidan, A. M. (2021). Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML). Cancers (Basel).
Citação norma ChicagoBewersdorf, Jan Philipp, and Amer M. Zeidan. "Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)." Cancers (Basel) 2021.
Citação norma MLABewersdorf, Jan Philipp, and Amer M. Zeidan. "Risk-Adapted, Individualized Treatment Strategies of Myelodysplastic Syndromes (MDS) and Chronic Myelomonocytic Leukemia (CMML)." Cancers (Basel) 2021.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.